Back to Search
Start Over
CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
- Source :
- GlobeNewswire. January 5, 2023
- Publication Year :
- 2023
-
Abstract
- Collaboration will combine Moderna's mRNA technology with CytomX's Probody[sup.(R)] Platform to generate and develop therapeutics for oncology and non-oncology conditions CytomX to receive $35 million upfront payment with the potential [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.732315249